Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 12:0_16:1_17:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003758 AN006170 Untargeted lipidomics of gemcitabine-resistant cells Pancreas Human Cancer Victor Chang Cardiac Research Institute LC-MS
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST002283 AN003730 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire LC-MS
  logo